Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungbong Han

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 19, 2023
A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLDGi-Ae Kim, Yewan Park, Shin Ju Oh, et al.
Epidemiology and Health|July 26, 2024
Association between smoking status and subclinical coronary atherosclerosis in asymptomatic Korean individualsHyeji Lee, Jinhee Ha, Kyung Sun Park, et al.
Digestive Diseases and Sciences|August 25, 2014
Probability of high-risk colorectal neoplasm recurrence based on the results of two previous colonoscopiesHye Won Park, Seungbong Han, Ji Young Lee, et al.
American Heart Journal|November 14, 2017
Long-term outcomes of bypass grafting versus drug-eluting stenting for left main coronary artery disease: Results from the IRIS-MAIN registryPil Hyung Lee, Jong-Young Lee, Cheol Whan Lee, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2025
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular CarcinomaKanghee Park, Hye Won Lee, Euichang Kim, et al.
Plos One|November 5, 2020
A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinomaJonggi Choi, So-Hyun Kim, Seungbong Han, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2015
Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular CarcinomaYeonjung Ha, Seungbong Han, Ju Hyun Shim, et al.
Digestive Diseases and Sciences|November 18, 2017
Efficacy and Safety of Fully Covered Self-Expanding Metal Stents for Malignant Esophageal ObstructionHoonsub So, Ji Yong Ahn, Seungbong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2026
Maintenance of PARP Inhibitor Rechallenge Plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP InhibitorHyun-Woong Cho, Jeong-Yeol Park, Myong Cheol Lim, et al.
Tumori|December 2, 2017
Risk prediction model for disease-free survival in women with early-stage cervical cancers following postoperative (chemo)radiotherapyHyoung Uk Je, Seungbong Han, Young Seok Kim, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Liver International : Official Journal of the International Association for the Study of the Liver|December 19, 2023
A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLDGi-Ae Kim, Yewan Park, Shin Ju Oh, et al.
Epidemiology and Health|July 26, 2024
Association between smoking status and subclinical coronary atherosclerosis in asymptomatic Korean individualsHyeji Lee, Jinhee Ha, Kyung Sun Park, et al.
Digestive Diseases and Sciences|August 25, 2014
Probability of high-risk colorectal neoplasm recurrence based on the results of two previous colonoscopiesHye Won Park, Seungbong Han, Ji Young Lee, et al.
American Heart Journal|November 14, 2017
Long-term outcomes of bypass grafting versus drug-eluting stenting for left main coronary artery disease: Results from the IRIS-MAIN registryPil Hyung Lee, Jong-Young Lee, Cheol Whan Lee, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2025
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular CarcinomaKanghee Park, Hye Won Lee, Euichang Kim, et al.
Plos One|November 5, 2020
A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinomaJonggi Choi, So-Hyun Kim, Seungbong Han, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2015
Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular CarcinomaYeonjung Ha, Seungbong Han, Ju Hyun Shim, et al.
Digestive Diseases and Sciences|November 18, 2017
Efficacy and Safety of Fully Covered Self-Expanding Metal Stents for Malignant Esophageal ObstructionHoonsub So, Ji Yong Ahn, Seungbong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2026
Maintenance of PARP Inhibitor Rechallenge Plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP InhibitorHyun-Woong Cho, Jeong-Yeol Park, Myong Cheol Lim, et al.
Tumori|December 2, 2017
Risk prediction model for disease-free survival in women with early-stage cervical cancers following postoperative (chemo)radiotherapyHyoung Uk Je, Seungbong Han, Young Seok Kim, et al.
Pageof 18